Evaluation of the Continuation of Anti-osteoporotic Treatment 1 Year After Initial Administration Following Severe Osteoporotic Fracture in Patients Aged 75 and Over, Hospitalized at the Rocheplane Medical Center
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 250
- 主要终点
- Evaluate the rate of continuation of anti-osteoporotic treatment at 1 year after initial administration following a severe osteoporotic fracture in patients aged 75 and over.
研究概览
简要总结
The aim of this observational study is to assess the obstacles and levers to the continuation of anti-osteoporotic treatment, and to identify those where action could be taken to improve the quality of care for fractured patients.
The individual and collective stakes are high. Fracture is the most feared complication of osteoporosis. The current under-diagnosis and under-treatment of this chronic pathology exposes patients to a high risk of early re-fracture, with the associated morbidity and mortality.
General practitioners have a major role to play in monitoring and coordinating patients' healthcare pathways. The aim of this study is to assess ways of improving osteoporosis management in order to improve quality of life and disability-free life expectancy for individual patients. The public health and economic stakes are equally high. It is by identifying the obstacles that prospective work on the key elements to be implemented could help optimize osteoporosis management.
详细描述
Selection of patients hospitalized at the Rocheplane Medical Center between June 2021 and May 2022, following a severe osteoporotic fracture and having received a first dose of antiosteoporotic treatment during their overall stay (initial admission department + CMR).
Sending of an information letter and request for non-objection from patients or their trusted support person, with a 1-month cooling-off period to express opposition.
Collection of variables of interest from CMR patients' medical records, followed by administration of a telephone hetero-questionnaire (transferred to Excel) to patients or their families 1 year after fracture occurrence.
If the patient or family did not answer the questionnaire, or if it was incomplete (missing data), the information could be sought by telephone from the attending physician.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 75 Years 至 —（Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Hospitalization in CMR's Geriatric Rehabilitation Department between 01/06/2021 and 31/05/2022
- •Age: 75 and over
- •Admitted with severe post-fracture osteoporosis
- •Having received a first dose of antiosteoporotic treatment between the day the fracture occurred and discharge from CMR (either in an inpatient unit prior to CMR, or at CMR)
排除标准
- •Having objected to the use of his/her data for research purposes
- •Subject under guardianship or deprived of liberty.
- •Pathological fracture
- •Anti-osteoporotic treatment prior to fracture
- •1-year follow-up made impossible by lack of contact with patient, family or attending physician.
结局指标
主要结局
Evaluate the rate of continuation of anti-osteoporotic treatment at 1 year after initial administration following a severe osteoporotic fracture in patients aged 75 and over.
时间窗: Telephone data collection one year after Geriatric Rehabilitation Department stay
Percentage of patients for whom anti-osteoporosis treatment was renewed 1 year after initial administration (between fracture occurrence and discharge from the geriatric department)
次要结局
- Determine the obstacles and levers to the continuation of treatment at 1 year after a fracture, in relation to the treating physician.(Telephone data collection one year after Geriatric Rehabilitation Department stay)
- Determine the obstacles and levers to the continuation of treatment at 1 year for fractures related to the healthcare system(Telephone data collection one year after Geriatric Rehabilitation Department stay)
- Identify patient-related obstacles and levers to treatment renewal at 1 year after fracture(Telephone data collection one year after Geriatric Rehabilitation Department stay)
- Determine the rate of introduction of anti-osteoporotic treatment during the patient's overall stay(Medical records collected one year after Geriatric Rehabilitation Department stay)
- Evaluation of the professional practices of general practitioners concerning the management of osteoporosis.(Telephone data collection one year after Geriatric Rehabilitation Department stay of their patient)